中老年人群高血压在非甾体抗炎药暴露与心脑血管疾病风险关联中的中介分析

doi:10.6040/j.issn.1671-7554.0.2023.0224

摘要/Abstract

摘要： 目的探讨高血压在非甾体抗炎药(NSAIDs)暴露与心脑血管疾病风险关联中的中介效应。方法基于国家健康医疗大数据研究院平邑协作中心平台构建随访队列,NSAIDs暴露定义为每年累积剂量(cDDDs)≥30,分别采用广义估计方程模型(GEE)和Cox比例风险回归模型估计NSAIDs与血压及心脑血管疾病之间的关联。采用Baron-Kenny法探究高血压在NSAIDs与心脑血管疾病关联中的中介效应。结果随访队列共纳入81 791例研究对象,中位随访时间4.25(IQR:3.22~4.46)年,心脑血管疾病发生结局26 514例。多因素GEE结果显示,NSAIDs暴露与收缩压升高(β=0.98,95%CI:0.67~1.29)、舒张压降低(β=-0.19,95%CI:-0.37~-0.01)及高血压风险增加(OR=1.13,95%CI:1.08~1.18)均呈显著相关;多因素Cox模型显示,NSAIDs与心脑血管疾病、脑血管疾病及心血管疾病关联的HR分别为1.13(95%CI:1.10~1.16)、1.13(95%CI:1.09~1.17)和1.17(95%CI:1.13~1.21)。中介分析发现,高血压在NSAIDs暴露与心脑血管疾病关系中起到部分中介作用,中介比例为9.27%。结论 NSAIDs有升高收缩压、降低舒张压的作用,是心脑血管疾病发病的危险因素。高血压是NSAIDs和心脑血管疾病之间的中介因素。

关键词: 非甾体抗炎药, 高血压, 心脑血管疾病, 队列研究, 中介效应

Abstract: Objective To explore the mediation effects of hypertension on the association between exposure to non-steroidal anti-inflammatory drugs(NSAIDs)and the risk of cardio-cerebrovascular diseases. Methods A follow-up cohort was constructed based on Pingyi Collaboration Center of National Institute of Health and Medical Big Data. NSAIDs exposure was defined as annual cumulative dose ≥30 cDDDs. The association between NSAIDs and blood pressure and cardio-cerebrovascular diseases were assessed with generalized estimation equation model(GEE)and Cox proportional risk regression model. The mediating effects of hypertension were evaluated with Baron-Kenny method. Results A total of 81,791 subjects were involved. The median follow-up time was 4.25(IQR: 3.22-4.46)years, with 26,514 cardio-cerebrovascular disease outcomes. Multivariate GEE results showed that NSAIDs exposure was significantly associated with increased systolic blood pressure(β=0.98, 95%CI: 0.67-1.29), decreased diastolic blood pressure(β=-0.19, 95%CI: -0.37 - 0.01), and increased risk of hypertension(OR=1.13, 95%CI: 1.08-1.18). Multivariate Cox model showed that the HR of NSAIDs associated with cardio-cerebrovascular diseases, cerebrovascular diseases and cardiovascular diseases were 1.13(95%CI: 1.10-1.16), 1.13(95%CI: 1.09-1.17)and 1.17(95%CI: 1.13-1.21), respectively. Mediation analysis showed that hypertension played a partial mediating role in the relationship between NSAIDs exposure and cardio-cerebrovascular diseases, with a mediating proportion of 9.27%. Conclusion NSAIDs, which can increase systolic blood pressure and decrease diastolic blood pressure, is a risk factor for cardio-cerebrovascular diseases. Hypertension is a mediating factor between NSAIDs and cardio-cerebrovascular diseases.

Key words: Non-steroidal anti-inflammatory drugs, Hypertension, Cardio-cerebrovascular diseases, Cohort study, Mediating effects

中图分类号:

于晴晴,常开锋,李吉庆,张凯,付苹,刘晓雯,赵英淇,薛付忠. 中老年人群高血压在非甾体抗炎药暴露与心脑血管疾病风险关联中的中介分析[J]. 山东大学学报 (医学版), 2023, 61(8): 79-85.

YU Qingqing, CHANG Kaifeng, LI Jiqing, ZHANG Kai, FU Ping,LIU Xiaowen, ZHAO Yingqi, XUE Fuzhong. Mediation effects of hypertension on the association between exposure to non-steroidal anti-inflammatory drugs and risk of cardio-cerebrovascular diseases in middle-aged and elderly people[J]. Journal of Shandong University (Health Sciences), 2023, 61(8): 79-85.

参考文献

[1] 蔡青青, 沈赟, 戴佩芳, 等. 非甾体类抗炎药物与高血压风险的研究进展[J]. 中国临床药学杂志, 2016, 25(5): 329-332. CAI Qingqing, SHEN Yun, DAI Peifang, et al. Research progress of nonsteroidal anti-inflammatory drugs and hypertension risk[J]. Chinese Journal of Clinical Pharmacy, 2016, 25(5): 329-332.
[2] El-Yazbi AF, Eid AH, El-Mas MM. Cardiovascular and renal interactions between cyclosporine and NSAIDs: underlying mechanisms and clinical relevance [J]. Pharmacol Res, 2018, 129: 251-261. doi: 10.1016/j.phrs.2017.11.029.
[3] 罗桢敏, 杨科朋, 陈劲柏, 等. 从NSAIDs心血管不良反应机制探讨老年人用药管理[J]. 中国药物滥用防治杂志, 2021, 27(5): 707-710. LUO Zhenmin, YANG Kepeng, CHEN Jinbai, et al. Discussion on medication management in the elderly from the mechanism of cardiovascular adverse reactions of NSAIDs [J]. Chinese Journal of Drug Abuse Prevention and Treatment, 2021, 27(5): 707-710.
[4] Liew JW, Ward MM, Reveille JD, et al. Nonsteroidal antiinflammatory drug use and association with incident hypertension in ankylosing spondylitis [J]. Arthritis Care Res(Hoboken), 2020, 72(11): 1645-1652.
[5] Ricciotti E, Castro C, Tang SY, et al. Cyclooxygenase-2, Asymmetric Dimethylarginine, and the Cardiovascular Hazard from Nonsteroidal Anti-Inflammatory Drugs [J]. Circulation, 2018, 138(21): 2367-2378.
[6] Ruschitzka F, Borer JS, Krum H, et al. Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM(prospective randomized evaluation of celecoxib integrated safety versus ibuprofen or naproxen ambulatory blood pressure measurement)trial [J]. Eur Heart J, 2017, 38(44): 3282-3292.
[7] Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of(non-aspirin)NSAIDs [J]. Nat Rev Cardiol, 2020, 17(9): 574-584.
[8] García-Poza P, de Abajo FJ, Gil MJ, et al. Risk of ischemic stroke associated with non-steroidal anti-inflammatory drugs and paracetamol: a population-based case-control study [J]. J Thromb Haemost, 2015, 13(5): 708-718.
[9] Chen AI, Lee YH, Perng WT, et al. Celecoxib and Etoricoxib may reduce risk of ischemic stroke in patients with rheumatoid arthritis: a nationwide retrospective cohort study [J]. Front Neurol, 2022, 13: 1018521. doi: 10.3389/fneur.2022.1018521.
[10] Barthélémy O, Limbourg T, Collet JP, et al. Impact of non-steroidal anti-inflammatory drugs(NSAIDs)on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors [J]. Int J Cardiol, 2013, 163(3): 266-271.
[11] 施倩雯, 魏永越, 李清雅, 等. 疾病预后研究的中介分析方法评价[J]. 中国卫生统计, 2017, 34(3): 390-396. SHI Qianwen, WEI Yongyue, LI Qingya, et al. Evaluation of mediation analysis methods in survival data [J]. Chinese Journal of Health Statistics, 2017, 34(3): 390-396.
[12] 施倩雯. 生存资料的中介分析方法评价[D]. 南京: 南京医科大学, 2017.
[13] Morrison A, Ramey DR, van Adelsberg J, et al. Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertension [J]. Curr Med Res Opin, 2007, 23(10): 2395-2404.
[14] Spence JD, Grosser T, FitzGerald GA. Acetaminophen, nonsteroidal anti-inflammatory drugs, and hypertension [J]. Hypertension, 2022, 79(9): 1922-1926.
[15] Tso J, Hollowed C, Liu C, et al. Nonsteroidal anti-inflammatory drugs and cardiovascular risk in American football [J]. Med Sci Sports Exerc, 2020, 52(12): 2522-2528.
[16] Zhu L, Xu C, Huo X, et al. The cyclooxygenase-1/mPGES-1/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury [J]. Nat Commun, 2019, 10(1): 1888. doi: 10.1038/s41467-019-09492-4.
[17] Foy MC, Vaishnav J, Sperati CJ. Drug-induced hypertension [J]. Endocrinol Metab Clin North Am, 2019, 48(4): 859-873.
[18] Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs(NSAIDs)and organ damage: a current perspective [J]. Biochem Pharmacol,2020, 180: 114147. doi: 10.1016/j.bcp.2020.114147.
[19] Jo HA, Kim DK, Park S, et al. Cardiovascular risk of nonsteroidal anti-inflammatory drugs in dialysis patients: a nationwide population-based study [J]. Nephrol Dial Transplant, 2021, 36(5): 909-917.
[20] Schjerning Olsen AM, Gislason GH, McGettigan P, et al. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction [J]. JAMA, 2015, 313(8): 805-814.
[21] Masclee GMC, Straatman H, Arfè A, et al. Risk of acute myocardial infarction during use of individual NSAIDs: a nested case-control study from the SOS project [J]. PLoS One, 2018, 13(11): e0204746. doi: 10.1371/journal.pone.0204746.
[22] Bally M, Dendukuri N, Rich B, et al. Risk of acute myocardial infarction with NSAIDs in real world use: Bayesian meta-analysis of individual patient data [J]. BMJ, 2017, 357: j1909. doi: 10.1136/bmj.j1909.
[23] Mayor S. NSAIDs double risk of bleeding in patients taking antithrombotics after myocardial infarction, study finds [J]. BMJ, 2015, 350: h1043. doi: 10.1136/bmj.h1043.
[24] Trelle S, Reichenbach S, Wandel S, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis [J]. BMJ, 2011, 342: c7086. doi: 10.1136/bmj.c7086.
[25] Khan S, Andrews KL, Chin-Dusting JPF. Cyclo-Oxygenase(COX)inhibitors and cardiovascular risk: are non-steroidal anti-inflammatory drugs really anti-inflammatory? [J]. Int J Mol Sci, 2019, 20(17): 4262.
[26] 李志万, 石炜. 非甾体抗炎药物和抗血压药物联用对血压的影响[J]. 海峡药学, 2016, 28(6): 125-127. LI Zhiwan, SHI Wei. Effect of non-steroidal anti-inflammatory drugs combined with antihypertensive drugs on blood pressure [J]. Strait Pharmaceutical Journal, 2016, 28(6): 125-127.
[27] Ingrasciotta Y, Sultana J, Giorgianni F, et al. Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study [J]. PLoS One, 2015, 10(4): e0122899. doi: 10.1371/journal.pone.0122899.
[28] Floor-Schreudering A, De Smet PA, Buurma H, et al. NSAID-antihypertensive drug interactions: which outpatients are at risk for a rise in systolic blood pressure? [J]. Eur J Prev Cardiol, 2015, 22(1): 91-99.

相关文章 15

[1]	吴逸南葛志明李方贺红姜虹张运. 自发性高血压大鼠肾脏血管紧张素转换酶2的表达[J]. 山东大学学报(医学版), 2209, 47(6): 5-.
[2]	孙红林,管玉强,于培儒,李磊,杜庆霞,丁浩. 支架植入治疗儿童主动脉缩窄并高血压的可行性及近中期疗效[J]. 山东大学学报 (医学版), 2026, 64(4): 58-62.
[3]	逄锦宏,苏萍,乔俊鹏,陈巧巧,陈学禹,赵颖颖,施婕,孙晓茹,李秋春,何蕊言,范轶欧,迟蔚蔚. 老年人群可改变心血管危险因素聚集模式与脑卒中的关联[J]. 山东大学学报 (医学版), 2025, 63(9): 11-19.
[4]	王乐,罗清馨,吴思佳,吴雨桐,葛祎蕾,俞一凡,韦云,吉寒冰,刘铁梅,张紫妍,修佳伟,薛付忠,李洪凯. 虚弱和癫痫关联研究:前瞻性队列和孟德尔随机化分析[J]. 山东大学学报 (医学版), 2025, 63(9): 20-30.
[5]	王宁,郝秀梅,牛翔,黄金明,徐静雅. 中国中老年高血糖、血脂异常、高血压人群健康体检服务利用现状及影响因素[J]. 山东大学学报 (医学版), 2025, 63(7): 82-91.
[6]	张艳艳,孙菁妮,朱凤英,杜以君,赵常梅,曹兴涛,张媛,吕明. 社会支持在脊髓损伤致神经源性膀胱患者自我管理与出院准备度间的中介作用[J]. 山东大学学报 (医学版), 2025, 63(3): 117-124.
[7]	王瑞,于康,刘燕萍. 维生素K₂与妊娠及妊娠相关疾病的研究进展[J]. 山东大学学报 (医学版), 2024, 62(8): 9-17.
[8]	范佳旭, 成芳,乔俊鹏,费海程,陈学禹,赵云,贾红英. 中介或混杂因素:是否应调整肥胖以估计三卤甲烷对甲状腺功能的影响[J]. 山东大学学报 (医学版), 2024, 62(1): 102-110.
[9]	韩梅,孟维静,陶子琨,杨希,徐雅琪,穆华夏,卜伟晓,王素珍,石福艳. 基于G-计算的高血压、抑郁在2型糖尿病与认知功能之间的因果多中介分析[J]. 山东大学学报 (医学版), 2023, 61(10): 101-108.
[10]	邬雨洁,张明泉,纪永利,赵璐,王越,陈沙沙. 寒痉汤及其拆方对寒凝证高血压大鼠血清炎症因子、血管内皮功能及纤维化的影响[J]. 山东大学学报 (医学版), 2022, 60(6): 10-18.
[11]	宋钰峰,宁豪,姚志刚,吴海虎,刘非凡,吕家驹. 肾上腺海绵状血管瘤临床及影像特征[J]. 山东大学学报 (医学版), 2022, 60(2): 37-42.
[12]	吕岩红,张志勉. 2 809名体检人群中高血压与幽门螺杆菌感染的关联性[J]. 山东大学学报 (医学版), 2022, 60(2): 43-47.
[13]	曹义海. 血管生成在疾病治疗中的应用与展望[J]. 山东大学学报 (医学版), 2021, 59(9): 9-14.
[14]	刘新雨,王权,琚号杰,孙晓杰. 认知功能在老年人社会资本与身体功能健康间的中介作用[J]. 山东大学学报 (医学版), 2021, 59(11): 100-107.
[15]	贾明旺,廖广园,熊明媚,徐文婷,王银玲,王懿春. 84例妊娠合并肺高血压患者预后的临床分析[J]. 山东大学学报 (医学版), 2021, 59(1): 34-39.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed